Therapeutical treatments

Therapeutical method of treating, by stimulation of the NK cells of a patient, of tumors and more generally of cancers of the group comprising breast cancer, lung cancer, oesophagus cancer, stomach cancer, intestine and colon cancers, and of viral, bacterial and fungal diseases as well as diseases related to immunostimulant deficiencies of human beings and warm-blood animals, comprising administration to a patient of an effective amount of especially soluble laminarin.

Therapeutical method of treating, by stimulation of the production of TNF-alpha, of tumors and more generally of cancers of the group comprising breast cancer, lung cancer, oesophagus cancer, stomach cancer, intestine and colon cancers, and of viral, bacterial and fungal diseases as well as diseases related to immunostimulant deficiencies of human beings and warm-blood animals, comprising administration to a patient of an effective amount of especially soluble laminarin.

Therapeutical method of treating tumors and more generally of cancers of the group comprising breast cancer, lung cancer, oesophagus cancer, stomach cancer, intestine and colon cancers, and of viral, bacterial and fungal diseases as well as diseases related to immunostimulant deficiencies of human beings and warm-blood animals, by intravenous administration of an amount of from 0.1 to 10 mg per day of preferably soluble laminarin.

Therapeutical method of treating tumors and more generally of cancers of the group comprising breast cancer, lung cancer, oesophagus cancer, stomach cancer, intestine and colon cancers, and of viral, bacterial and fungal diseases as well as diseases related to immunostimulant deficiencies of human beings and warm-blood animals, by intraperitoneally administration of from 0.1 to about 50 mg/kg per day during a period of from 5 to 15 days of preferably soluble laminarin.

Therapeutical method of treating tumors and more generally of cancers of the group comprising breast cancer, lung cancer, oesophagus cancer, stomach cancer, intestine and colon cancers, and of viral, bacterial and fungal diseases as well as diseases related to immunostimulant deficiencies of human beings and warm-blood animals, by oral administration, of from 1 to 100 and, preferably, of about 10 mg/kg, advantageously twice a week over extended periods of time, of preferably soluble laminarin.

Combination therapy consisting in therapeutical treatment of tumors and more generally of cancers of the group comprising breast cancer, lung cancer, oesophagus cancer, stomach cancer, intestine and colon cancers, and of viral, bacterial and fungal diseases as well as diseases related to immunostimulant deficiencies of human beings and warm-blood animals, by administration of effective amounts of respectively laminarin and chemo-therapeutic agents or potentiators.